Meille, Christophe
89  Ergebnisse:
Personensuche X
?
1

Integration of Pharmacokinetics, Pharmacodynamics, Safety, ..:

Wilbaux, Mélanie ; Yang, Shu ; Jullion, Astrid...
Clinical Pharmacology & Therapeutics.  112 (2022)  6 - p. 1329-1339 , 2022
 
?
2

Contribution of machine learning to tumor growth inhibition..:

Wilbaux, Mélanie ; Demanse, David ; Gu, Yi...
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  8 - p. 1122-1134 , 2022
 
?
5

A framework to guide dose & regimen strategy for clinical d..:

Sander, Oliver ; Magnusson, Baldur ; Ludwig, Inga...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  11 - p. 1276-1280 , 2021
 
?
9

Revisiting dosing regimen using PK/PD modeling: the MODEL1 ..:

Hénin, Emilie ; Meille, Christophe ; Barbolosi, Dominique...
Breast Cancer Research and Treatment.  156 (2016)  2 - p. 331-341 , 2016
 
?
12

Model-based assessment of erlotinib effect in vitro measure..:

Benay, Stephan ; Meille, Christophe ; Kustermann, Stefan...
Journal of Pharmacokinetics and Pharmacodynamics.  42 (2015)  3 - p. 275-285 , 2015
 
?
13

Preclinical pharmacokinetics, pharmacodynamics, and efficac..:

Meneses-Lorente, Georgina ; Friess, Thomas ; Kolm, Irene...
Cancer Chemotherapy and Pharmacology.  75 (2015)  4 - p. 837-850 , 2015
 
?
 
?
15

Translational PK/PD modeling for cardiovascular safety asse..:

Caruso, Antonello ; Frances, Nicolas ; Meille, Christophe...
Journal of Pharmacological and Toxicological Methods.  70 (2014)  1 - p. 73-85 , 2014
 
1-15